We are monitoring the impact of COVID-19 on North America Insulin Delivery Devices Market Get in touch with us for detailed analysis Know More
Share on

North America Insulin Delivery Devices Market Research Report - By Type, Application and Country (the United States, Canada and Rest of North America) - Industry Analysis, Size, Share, Trends, Growth & Forecast (2022 to 2027)

Published: January, 2022
ID: 227
Pages: 135

North America Insulin Delivery Devices Market Size (2022 to 2027)

According to our report, the size of the North American insulin delivery devices market is predicted to worth USD 18.48 billion by 2027, from USD 13.18 billion in 2022. The market is growing at a CAGR of 6.99% from 2022 to 2027.

The insulin delivery devices market is solely dependent on the growing population of people with diabetes. There has been an incredible rise in the prevalence of diabetes in hospitals in the North American area in recent years. Insulin in North America maintains blood sugar levels and is vital for people with type I diabetes & type II diabetes. Insulin delivery systems have been helped to evolve over the past few years. Such machines are used instead of the oral route of administration to administer insulin doses via the parenteral route.

Insulin delivery systems facilitate the level of insulin absorption from the injection site into the bloodstream to trigger insulin's rapid pharmacological effect among the most widely used insulin delivery devices like insulin syringes, insulin pens, pen needles for insulin, insulin pumps, and insulin jet injectors.

The growth of the demand for diabetes care devices in the region is mainly due to the increasing geriatric population and rapid developments in diabetes care devices.

However, high costs of diabetes treatment services and the risks associated with insulin delivery systems are likely to harm market growth. Strict regulatory laws and regulations for product authorization and minimal penetration of advanced insulin delivery systems in this area also restrict the growth of the North American market for insulin delivery devices. On the other hand, cost-effective pen needle design will have a positive influence on the expansion of the demand for diabetes care devices in North America in the years to come.

This research report on the North American Insulin Delivery Devices Market has been segmented and sub-segmented into the following categories:

By Type: 

  • Insulin Syringes
  • Insulin Pens
  • Insulin Pen Needles
  • Insulin Pumps
  • Insulin Jet Injectors

By Application: 

  • Type I Diabetes
  • Type II Diabetes

By Country: 

  • The United States
  • Canada
  • Rest of North America

Based on the region, The U.S. insulin delivery devices market accounted for a more significant share of the North American market in the last few years. On the other hand, Canada is expected to grow at a more considerable CAGR throughout the forecast period. As per the Centers for Disease Control and Prevention (CDC), last year, 30.3 million people in the U.S. were diagnosed with diabetes, including 23.1 million women, and 7.2 million patients left undiagnosed. Thus, high diabetes prevalence and significant diagnostic rates through easy accessibility of technologically sophisticated devices further fuel the market's regional growth.

Companies playing a dominant role in the North American Insulin Deliver Devices Market profiled in this report are Becton, Dickinson, and Company (U.S.), Sanofi (France), Novo Nordisk A/S (Denmark), Julphar (U.A.E.), Eli Lilly and Company (U.S.), Biocon Ltd. (India), Ypsomed AG (Switzerland), Wockhardt Ltd. (India), B. Braun Meselgen AG (Switzerland) and Biodel Inc. (U.S.).

1. Introduction                                                                                 

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                          

                1.4 General Study Assumptions                                                                

2. Research Methodology                                                                                           

                2.1 Introduction                                                                               

                2.2 Research Phases                                                                      

                                2.2.1 Secondary Research                                                           

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                      

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design                                                                         

                2.4 Study Timeline                                                                          

3. Overview                                                                                       

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 New Developments                                                                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                                    

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                                              

5. Market Segmentation                                                                                              

                5.1 Introduction                                                                               

                5.2 Type                                                                              

                                5.2.1 Introduction                                                           

                                5.2.2 Insulin Syringes                                                     

                                5.2.3 Insulin Pens                                                            

                                5.2.4 Insulin Pen Needles                                                            

                                5.2.5 Insulin Pumps                                                        

                                5.2.6 Insulin Jet Injectors                                                             

                5.3 Application                                                                 

                                5.3.1 Introduction                                                           

                                5.3.2 Type I Diabetes                                                     

                                5.3.3 Type II Diabetes                                                    

6. Geographical Analysis                                                                                              

                                6.1 Introduction                                                               

                                6.2 United States                                                            

                                6.3 Canada                                                         

7. Strategic Analysis                                                                                       

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

8. Market Leaders' Analysis                                                                                        

                8.1 Sanofi (France)                                                                         

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Strategic Evaluation and Operations                                                            

                                8.1.4 Financial analysis                                                  

                                8.1.5 Legal issues                                                             

                                8.1.6 Recent Developments                                                       

                                8.1.7 SWOT analysis                                                       

                                8.1.8 Analyst View                                                          

                8.2 Novo Nordisk A/S (Denmark)                                                                             

                8.3 Eli Lilly and Company (U.S.)                                                                  

                8.4 Biocon Ltd. (India)                                                                   

                8.5 Julphar (U.A.E.)                                                                        

                8.6 Ypsomed AG (Switzerland)                                                                  

                8.7 Becton, Dickinson and Company (U.S.)                                                                          

                8.8 Wockhardt Ltd. (India)                                                                           

                8.9 B. Braun Meselgen AG (Switzerland)                                                                              

                8.10 Biodel Inc. (U.S.)                                                                    

9. Competitive Landscape                                                                                           

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                                         

                9.4 New Product Launches                                                                         

10. Expert Opinions                                                                                        

                10.1 Market Outlook                                                                     

                10.2 Investment Opportunities                                                                 

Appendix                                                                                           

                a) List of Tables                                                                

                b) List of Figures                                                                              

  1. North America Insulin Delivery Devices Market, By Region, From 2022 - 2027 (USD Million)
  2. North America Insulin Delivery Devices Market, By Type, From 2022 - 2027 (USD Million)
  3. North America Insulin Syringes Market, By Region, From 2022 - 2027 (USD Million)
  4. North America Insulin Pens Market, By Region, From 2022 - 2027 (USD Million)
  5. North America Insulin Pen Needles Market, By Region, From 2022 - 2027 (USD Million)
  6. North America Insulin Pumps Market, By Region, From 2022 - 2027 (USD Million)
  7. North America Insulin Jet Injectors Market, By Region, From 2022 - 2027 (USD Million)
  8. North America Insulin Delivery Devices Market, By Application, From 2022 - 2027 (USD Million)
  9. North America Type I Diabetes of Insulin Delivery Devices Market, By Region, From 2022 - 2027 (USD Million)
  10. North America Type II Diabetes of Insulin Delivery Devices Market, By Region, From 2022 - 2027 (USD Million)
  11. United States Insulin Delivery Devices Market, By Type, From 2022 - 2027 (USD Million)
  12. United States Insulin Delivery Devices Market, By Application, From 2022 - 2027 (USD Million)
  13. Canada Insulin Delivery Devices Market, By Type, From 2022 - 2027 (USD Million)
  14. Canada Insulin Delivery Devices Market, By Application, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample